Federal Contractor Profile
Fundacion Inciensa
Federal contracting record: $115M obligated across 14 awards from 1 agencies, FY 2016–2026.
Company Profile
UEI (Unique Entity Identifier)
KDL2VERNRKA5
CAGE Code
SFF99
Parent Organization
Fundacion Inciensa
Address
ROHRMOSER 200 N 75 O BANCO BCT, SAN JOSE, 40201
First Federal Award
Oct 27, 2015
Most Recent Award
Jan 22, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
No agency data.
Top NAICS Activity
- $104M
541720
RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES
12 awards
- $6.9M
541990
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
1 awards
- $3.9M
541712
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
1 awards
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Jan 22, 2026 | Department of Health and Human ServicesNIH NCI | 541720 | PRISMA AND EXTEND 2.0 FOLLOW-UP OF STUDY PARTICIPANTS | $1.5M |
| May 21, 2025 | Department of Health and Human ServicesNIH NCI | 541720 | EXTENSION OF ESCUDDO FOLLOW-UP FROM FIVE YEARS TO 7.5 YEARS (REFERRED TO AS ESCUDDO-7) WILL EVALUATE THE DURABILITY OF THE NON-INFERIORITY OF PROTECTION AFFORDED BY ONE VERSUS TWO DOSES OF THE HPV VACCINES. | $6.0M |
| May 8, 2025 | Department of Health and Human ServicesNIH NCI | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $227K |
| Mar 13, 2025 | Department of Health and Human ServicesNIH NCI | 541720 | EXTENSION OF ESCUDDO FOLLOW-UP FROM FIVE YEARS TO 7.5 YEARS (REFERRED TO AS ESCUDDO-7) WILL EVALUATE THE DURABILITY OF THE NON-INFERIORITY OF PROTECTION AFFORDED BY ONE VERSUS TWO DOSES OF THE HPV VACCINES. | $3.6M |
| Dec 20, 2024 | Department of Health and Human ServicesNIH NCI | 541720 | PRISMA AND EXTEND 2.0 FOLLOW-UP OF STUDY PARTICIPANTS | $2.4M |
| Sep 11, 2024 | Department of Health and Human ServicesNIH NCI | 541720 | LAB TESTING OF BIOSPECIMENS COLLECTED FROM PARTICIPANTS OF THE NCI'S HPV VACCINE STUDIES | $650K |
| Sep 5, 2024 | Department of Health and Human ServicesNIH NCI | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $3.1M |
| Aug 29, 2024 | Department of Health and Human ServicesNIH NCI | 541720 | KICK-OFF OF EPIDEMIOLOGY AND PREVENTION OF INFECTIONS AND RELATED DISEASES IDIQ | $3K |
| Jan 22, 2024 | Department of Health and Human ServicesNIH NCI | 541720 | PRISMA AND EXTEND 2.0 FOLLOW-UP OF STUDY PARTICIPANTS | $1.7M |
| Sep 11, 2023 | Department of Health and Human ServicesNIH NCI | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $9.0M |
| Aug 28, 2023 | Department of Health and Human ServicesNIH NCI | 541720 | LAB TESTING OF BIOSPECIMENS COLLECTED FROM PARTICIPANTS OF THE NCI'S HPV VACCINE STUDIES | $538K |
| Jan 10, 2023 | Department of Health and Human ServicesNIH NCI | 541720 | PRISMA AND EXTEND 2.0 FOLLOW-UP OF STUDY PARTICIPANTS | $1.4M |
| Sep 19, 2022 | Department of Health and Human ServicesNIH NCI | 541720 | LAB TESTING OF BIOSPECIMENS COLLECTED FROM PARTICIPANTS OF THE NCI'S HPV VACCINE STUDIES | $197K |
| Sep 2, 2022 | Department of Health and Human ServicesNIH NCI | 541720 | FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL | $239K |
| Aug 31, 2022 | Department of Health and Human ServicesNIH NCI | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $9.4M |
| Nov 15, 2021 | Department of Health and Human ServicesNIH NCI | 541720 | THIS TASK ORDER DESCRIBES ACTIVITIES RELATED TO NCIS HUMAN PAPILLOMAVIRUS HPV VACCINE EVALUATION EFFORTS REQUIRED FOR THE NEXT PHASE OF THE RESEARCH | $4.0M |
| Sep 14, 2021 | Department of Health and Human ServicesNIH NCI | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $9.3M |
| Sep 14, 2021 | Department of Health and Human ServicesNIH NCI | 541720 | FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL | $296K |
| Aug 31, 2021 | Department of Health and Human ServicesNIH NCI | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $7K |
| Sep 21, 2020 | Department of Health and Human ServicesNIH NCI | 541720 | TO STUDY COVID TRANSMISSION IN COSTA RICA | $366K |
| Sep 15, 2020 | Department of Health and Human ServicesNIH NCI | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $8.6M |
| Sep 15, 2020 | Department of Health and Human ServicesNIH NCI | 541720 | FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL | $261K |
| Jul 31, 2020 | Department of Health and Human ServicesNIH NCI | 541720 | TO STUDY COVID TRANSMISSION IN COSTA RICA | $334K |
| Sep 16, 2019 | Department of Health and Human ServicesNIH NCI | 541720 | FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL | $73K |
| Sep 9, 2019 | Department of Health and Human ServicesNIH NCI | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $8.6M |
Related Contractors
Other companies active in NAICS 541720 — RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES.
Track Fundacion Inciensa Recompetes Before They Post
Mindy monitors Fundacion Inciensa's active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.
Get Free Recompete Alerts